Charles Sang, SVP, Clinical Diagnostics at Adaptive Biotechnologies Corp (ADPT), sold 40,000 shares at $38.01 ($1.5M) on 2020-05-15, disclosed to the SEC on 2020-05-18.
Open-market sale of $1.5M ADPT by SVP, Clinical Diagnostics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |